Skip to main content
CARMAT logo

CARMAT — Investor Relations & Filings

Ticker · ALCAR ISIN · FR0010907956 LEI · 969500ARXACM0P0KH333 PA Manufacturing
Open in API
Filings indexed 570 across all filing types
Latest filing 2020-01-07 Report Publication Anno…
Country FR France
Listing PA ALCAR

About CARMAT

https://www.carmatsa.com/en/

CARMAT is a medical technology company that designs, develops, and markets the Aeson® total artificial heart. This bioprosthetic device provides a therapeutic solution for patients suffering from end-stage biventricular heart failure. Aeson® is designed to replace the native heart, primarily as a bridge to transplantation for eligible patients. A key feature of the device is its self-regulation capability, which uses embedded sensors and biocompatible materials to automatically adapt blood flow based on the patient's physiological needs, thereby mimicking the function of a natural heart.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Report Publication Announcement Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and its main content is the "Agenda financier 2020" (2020 Financial Calendar). It explicitly lists future dates for key events like the 2019 Annual Financial Results, the Annual General Meeting (Assemblée générale annuelle), and the 2020 Semi-annual Financial Results. Since this document is an announcement detailing the schedule of future corporate events, rather than the full report itself (like a 10-K or IR), it best fits the category for announcing the publication or timing of reports. The closest specific category is Report Publication Announcement (RPA), as it announces the dates for the release of financial results and the AGM. However, since it is a general announcement of the financial schedule, and not specifically announcing the *publication* of a report that is attached or linked (which would strongly suggest RPA), and given the inclusion of the AGM date, it could also be considered related to AGM information or a general regulatory filing. Given the structure, it is a forward-looking announcement of key dates. If a specific category for 'Financial Calendar Announcement' existed, it would fit there. Among the provided options, it is a general corporate announcement. Since it details the date of the 'Assemblée générale annuelle' (AGM), AGM-R is a possibility, but AGM-R is defined as 'Presentations and materials shared during the Annual General Meeting'. This document *announces* the AGM date. The most fitting general category for an announcement about future corporate events/reports is RPA or RNS. Given the focus on the financial calendar including the AGM date, and the fact that it is a press release announcing future events, RPA (Report Publication Announcement) is a strong candidate, as it announces when reports will be published. However, since it is a general schedule announcement, RNS (Regulatory Filings - fallback) is also plausible if RPA is too specific. Let's re-evaluate: It announces the date of the AGM (AGM-R material) and the dates of financial results (ER/IR material). Since it is a schedule announcement, RPA is the best fit for announcing *when* these events/reports will occur. I will select RPA as it announces the publication schedule for key corporate events/reports.
2020-01-07 French
Acquisition ou cession des actions de l'émetteur / Information relative au contrat de liquidité
Capital/Financing Update Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and its primary content is the "Bilan semestriel du contrat de liquidité" (Semi-annual statement of the liquidity contract) as of December 31, 2019, detailing shares and cash held by the liquidity provider (Gilbert Dupont). This type of announcement, reporting on the status of a liquidity agreement, is a routine corporate disclosure. It is not a full Annual Report (10-K), an Interim Report (IR), an Earnings Release (ER), or a Dividend Notice (DIV). It is a specific regulatory/corporate action update. Since it details the status of a financial arrangement (liquidity contract) and is presented as a press release, it fits best under the general category of Regulatory Filings (RNS) as a miscellaneous corporate action announcement, or potentially Capital/Financing Update (CAP) due to its relation to share trading mechanisms. However, given the specific nature of reporting on a liquidity contract balance, and lacking a more specific category for 'Liquidity Contract Status', RNS serves as the most appropriate general regulatory disclosure category for this type of routine filing that isn't explicitly covered elsewhere. It is short and structured like an announcement, not a comprehensive report.
2020-01-03 French
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is very short (1021 characters) and explicitly states it is a 'Déclaration au titre de l'article 223-16 du règlement général de l'Autorité des marchés financiers' (Declaration under Article 223-16 of the General Regulation of the AMF). It provides a table detailing the 'Nombre total de droits de vote et d'actions composant le capital social' (Total number of shares and voting rights) as of a specific date (31.12.2019). This structure—a brief regulatory declaration providing updated share/voting capital figures—is characteristic of a formal regulatory filing that is not a full report (like 10-K or IR). Since there is no specific category for 'Total Voting Rights Declaration,' the most appropriate general regulatory filing category is 'Regulatory Filings' (RNS), as it is a mandatory, periodic disclosure to the market regulator.
2020-01-02 French
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and announces a specific operational update: the resumption of enrollment in the PIVOTAL study and the implantation of a 12th patient. It includes a date (December 9, 2019), quotes from the CEO, and contact information for Press Relations and Investor Relations. This format is characteristic of an immediate, brief announcement of a significant event or result, rather than a comprehensive periodic report (like 10-K or IR) or a formal regulatory filing like a proxy statement or earnings release (ER). Since it is a press release announcing operational progress, it fits best under the general category for regulatory announcements or news releases that don't fit a more specific operational code. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a general press release of this nature, although 'ER' (Earnings Release) is sometimes used broadly for company updates, this is clearly not financial results. It is not a formal report itself, so RPA is less likely than RNS for a general news announcement.
2019-12-09 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and is dated December 9, 2019. It announces a specific operational update: CARMAT resuming recruitment in the PIVOT study in the Czech Republic by implanting its artificial heart in the 12th patient. This type of announcement, detailing operational milestones, clinical trial progress, or key business updates outside of formal periodic financial reporting (like 10-K or IR), typically falls under a general regulatory announcement or press release category. Since it is not a formal financial report (10-K, IR, ER), a management discussion (MDA), or a specific corporate action announcement (like DIV, CAP, DIRS), the most appropriate classification is the general regulatory announcement fallback, RNS (Regulatory Filings), as it is a formal communication to the market. It is not an Earnings Release (ER) as it focuses on clinical trial progress, not financial results. It is not an Investor Presentation (IP) or Fund Factsheet (FS). It is a direct announcement, not a notice about a report (RPA).
2019-12-09 French
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is explicitly titled 'PRESS RELEASE' and announces a specific operational update: 'CARMAT granted authorization to resume the PIVOTAL study in Kazakhstan'. It contains key highlights, quotes from the CEO, and standard boilerplate information about the company, contacts, and a disclaimer. This format is characteristic of an initial, brief announcement of material information, rather than a comprehensive periodic report (like 10-K or IR) or a transcript (CT). Since it is an announcement of operational/clinical progress, it does not fit perfectly into the financial-specific categories like ER or DIV. Given the options, this type of material, non-financial, operational update that is not a formal regulatory filing (like a 10-K) or a specific report announcement (like RPA) is best categorized as a general Regulatory Filing (RNS) or, if we interpret 'Earnings Release' (ER) broadly as a 'Periodical Release', it might fit there, but ER usually implies financial results. Since this is a press release announcing a clinical/operational milestone, and it is not a formal report itself, RNS (Regulatory Filings / miscellaneous announcements) is the most appropriate fallback, although it is a very specific type of announcement. However, looking closely at the definitions, none perfectly capture a clinical trial update press release. Given the context of financial reporting databases, press releases announcing operational milestones often fall under the general regulatory/news category. I will classify it as RNS as the best fit for a general, non-financial, material announcement that isn't covered by other specific codes.
2019-12-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.